ARCHIVES

Mytomycin C, RT Improve Head & Neck Results, Sartorelli Reports; Other AACR, ASCO Lectures

This article is from The Cancer Letter archive.

Vol. 13 No. 23 | June 5, 1987

Download PDF Visit The Full Archive

Related Articles

Phase III Alimta Trial Fails To Extend Progression-Free Survival Without Grade 4 Adverse Events

June 28, 2013

Kansas City Clinic Settles Medicare Overbilling Claim

June 6, 2014

“I Can’t Permit Destruction of NSABP,” Fisher Writes

September 9, 1994

Action Plan Steering committee votes 13-0 To Return $14 Million To NCI for Research

November 15, 1996

Raloxifene Protects Women At High or Low Risk of Disease

September 29, 2006

Cancer Panel To Form Committee On Breast Cancer

October 11, 1991